NCT06918301 Comparison of Cardiac Index and Stroke-volume-index Measured by Pulmonary Artery Catheter, FloTrac® and Argos® in Cardiac Surgery Patients.
| NCT ID | NCT06918301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karlsburg Hospital |
| Condition | Cardiac Failure Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-03-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A comparison of cardiac performance determined by stroke-volume-index measured by different mechanisms in patients during and after cardiac surgery: 1. Pulmonary artery catheter 2. Flo Trac 3. Argos Monitor Investigations will be done in theater and on ICU in ventilated and spontaneously breathing patients.
Eligibility Criteria
Inclusion Criteria: * Patient after cardiac surgery with pulmonary artery catheter Exclusion Criteria: * Hemodynamic instability, no consent
Contact & Investigator
Matthias Heringlake
PRINCIPAL INVESTIGATOR
Head of Department of Anesthesiology and intensive care, Karlsburg Hospital
Frequently Asked Questions
Who can join the NCT06918301 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Failure Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06918301 currently recruiting?
Yes, NCT06918301 is actively recruiting participants. Contact the research team at heringlake@t-online.de for enrollment information.
Where is the NCT06918301 trial being conducted?
This trial is being conducted at Karlsburg, Germany.
Who is sponsoring the NCT06918301 clinical trial?
NCT06918301 is sponsored by Karlsburg Hospital. The principal investigator is Matthias Heringlake at Head of Department of Anesthesiology and intensive care, Karlsburg Hospital. The trial plans to enroll 40 participants.